RETRACTED ARTICLE: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset

AbstractLiver carcinomas have been classified into three types: hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC). We aim to find the common and different characteristic of these three types of liver cancer. The gene expression profiling of HCC, CC, and CHC were compared with each other, and enrichment pathways and processes in these three liver cancers were also identified. Using GSE15765 datasets downloaded from NCBI GEO database, the gene expression profiling of HCC, CC, and CHC were compared with each other (HCC compared with CC, HCC compared with CHC, and CC compared with HCC). Then, the differentially expressed genes (DEGs) were identified in these three groups respectively, and three PPI networks were constructed for DEGs in each group. Subsequently, the clusters in these networks were identified and further analyzed by ClusterONE and MCODE. Finally, gene set enrichment analysis enrichment analysis was performed to illustrate altered pathways and processes for each type of liver cancer. A total of 112, 530, and 64 DEGs were identified in three groups, respectively, and three PPI networks were constructed respectively for the corresponding group. Through the cluster analysis, we found some new differential marker genes for distinguishing the difference between these three types of liver cancer. We also indicated that we can distinguish HCC with CC through altered pathways and processes. Our findings develop new biomarkers for categorizing the primary liver cancer and may improve patient prognosis of these cancers. However, further validation is required since our results were based on microarray data derived from a small sample size.

[1]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[2]  F. Callea,et al.  Pathology of hepatocellular carcinoma , 1993, Journal of surgical oncology. Supplement.

[3]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[4]  Mary Ann Comunale,et al.  Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. , 2006, Journal of proteome research.

[5]  Hui Gao,et al.  Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[6]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[7]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[8]  S. Fan,et al.  Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. , 1994, The New England journal of medicine.

[9]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[10]  Jennifer M. Rust,et al.  The BioGRID Interaction Database , 2011 .

[11]  W. Lau,et al.  Management of bile duct injury after laparoscopic cholecystectomy: a review , 2010, ANZ journal of surgery.

[12]  A. Wee,et al.  Combined Hepatocellular-Cholangiocarcinoma , 1999, Acta Cytologica.

[13]  K. Chayama,et al.  Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma , 2011, Hepatology.

[14]  M. Miyazaki,et al.  Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase , 2008, Hepatology.

[15]  N M Bass,et al.  Fatty‐acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis , 1993, Hepatology.

[16]  T. Derrick,et al.  Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. , 1994, Medicine and science in sports and exercise.

[17]  Jung-Hwan Yoon,et al.  Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[18]  I. Ng,et al.  Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication , 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[19]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[20]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Christie S. Chang,et al.  The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..

[22]  Walter Heindel,et al.  Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. , 2009, Blood.

[23]  K. Ishak,et al.  Combined hepatocellular‐cholangiocarcinoma. A histologic and immunohistochemical study , 1985, Cancer.

[24]  Y. Miyagi,et al.  Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. , 2006, Cancer research.

[25]  J. Luk,et al.  Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence* , 2008, Molecular & Cellular Proteomics.

[26]  C. Hawkey Textbook of clinical gastroenterology and hepatology , 2012 .

[27]  A. Burroughs,et al.  Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis. , 1999, Journal of hepatology.

[28]  Haiyuan Yu,et al.  Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[29]  W. V. Steenbergen,et al.  αl-Antitrypsin Deficiency: An Overview. , 1993, Acta clinica Belgica.

[30]  Akhilesh Pandey,et al.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. , 2008, Journal of proteome research.